A feasibility study: Can information collected to classify for mutagenicity be informative in predicting...

Area of Science:

• Toxicology and Carcinogenesis
• Computational Toxicology
• Regulatory Science

Background:

• The rodent bioassay for carcinogenicity is time-consuming, expensive, and ethically challenging.
• Developing accurate short-term and non-testing methods is crucial for predicting genotoxic carcinogenic potential.
• Previous work established an in vitro-in vivo extrapolation workflow to reconcile genotoxicity test differences.

Purpose of the Study:

• To refine an integrated approach to testing and assessment (IATA) for carcinogenicity prediction.
• To group in vitro and in vivo tests based on mechanistic understanding of DNA/protein damage detection.
• To rationalize inconsistent study outcomes and improve regulatory classification of carcinogens.

Main Methods:

• Grouping specific genotoxicity tests based on mechanistic endpoints (DNA/protein damage).
• Applying a revised workflow, informed by mechanistic understanding, as an Integrated Approach to Testing and Assessment (IATA).
• Utilizing mutagenicity data to categorize a test set of carcinogens according to regulatory classifications.

Main Results:

• The refined IATA workflow successfully rationalized inconsistent genotoxicity study outcomes.
• Rodent genotoxic carcinogens were predicted with high sensitivity (90-100%).
• The workflow demonstrated a low rate of false positives (3-10%) in carcinogen prediction.

Conclusions:

• The refined IATA workflow provides a robust, mechanistic-based approach for carcinogenicity assessment.
• This approach enhances the accuracy of regulatory mutagenicity classifications.
• The findings support the development of future non-testing strategies for regulatory toxicology.